title: Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.
authors.affiliation: CNS Department, University Hospital, London, Ontario, Canada.
authors.forename: B G
authors.initials: BG
authors.lastname: Weinshenker
authors.forename: B H
authors.initials: BH
authors.lastname: Bass
authors.forename: G C
authors.initials: GC
authors.lastname: Ebers
authors.forename: G P
authors.initials: GP
authors.lastname: Rice
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005121:Extremities; D005260:Female; D006801:Humans; D016853:Muromonab-CD3; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3